FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085285405> ?p ?o ?g. }

• W2085285405 endingPage "3340" @default.
• W2085285405 startingPage "3333" @default.
• W2085285405 abstract "Immunotherapy of canine visceral leishmaniasis (CVL) may provide an alternative to both marginally effective chemotherapy and undesired euthanasia of infected dogs and could have a great impact not only on animal welfare, but also on control of human disease. Therefore, we examined the potential immunotherapeutic efficacy of the subunit vaccine Leish-111f+MPL-SE, which has undergone rigorous preclinical testing and been demonstrated safe in human clinical trials. Two separate trials were performed in Salvador, Brazil, to evaluate the vaccine for therapeutic efficacy against CVL caused by natural infection: an Open Trial and a Blinded Trial. In the Open Trial 59 dogs with clinically active CVL were sequentially allocated to four groups: group 1 received Leish-111f+MPL-SE; group 2 was treated with Glucantime; group 3 received a combination of the vaccine and Glucantime; and group 4 was given no treatment. At the 6-month assessment, the 13 non-treated dogs had either died or showed no clinical improvement. In contrast, most dogs in groups 1-3 showed initial improvement (100%, 80%, and 92%, respectively). Upon evaluation for a mean of 36 months after therapy, the following cure rates were observed: 75% for group 1 dogs (exact 95% confidence interval [CI] 43-95%), 64% for group 2 dogs (exact 95% CI 31-89%), and 50% for group 3 dogs (exact 95% CI 19-81%). Therapeutic efficacy of the Leish-111f+MPL-SE vaccine was reconfirmed in a subsequent Blinded Trial. The vaccine was effective for mild cases of CVL and was compromised in dogs with severe disease. Although further studies are required to understand mechanisms of action, the Leish-111f+MPL-SE vaccine is a promising tool to control VL in both dogs and humans." @default.
• W2085285405 created "2016-06-24" @default.
• W2085285405 creator A5006151816 @default.
• W2085285405 creator A5007414771 @default.
• W2085285405 creator A5009314480 @default.
• W2085285405 creator A5010042657 @default.
• W2085285405 creator A5024322735 @default.
• W2085285405 creator A5054673363 @default.
• W2085285405 creator A5069585538 @default.
• W2085285405 creator A5072701661 @default.
• W2085285405 creator A5077951736 @default.
• W2085285405 creator A5015812124 @default.
• W2085285405 date "2010-04-01" @default.
• W2085285405 modified "2023-09-27" @default.
• W2085285405 title "Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE" @default.
• W2085285405 cites W1840052409 @default.
• W2085285405 cites W1974652725 @default.
• W2085285405 cites W1982589742 @default.
• W2085285405 cites W1982932318 @default.
• W2085285405 cites W1983902030 @default.
• W2085285405 cites W1995545582 @default.
• W2085285405 cites W1995725063 @default.
• W2085285405 cites W1998367326 @default.
• W2085285405 cites W2000482933 @default.
• W2085285405 cites W2003163436 @default.
• W2085285405 cites W2007306038 @default.
• W2085285405 cites W2023088528 @default.
• W2085285405 cites W2025899290 @default.
• W2085285405 cites W2033431194 @default.
• W2085285405 cites W2039947970 @default.
• W2085285405 cites W2046144222 @default.
• W2085285405 cites W2050886892 @default.
• W2085285405 cites W2053150635 @default.
• W2085285405 cites W2053293487 @default.
• W2085285405 cites W2083946109 @default.
• W2085285405 cites W2084208767 @default.
• W2085285405 cites W2085212996 @default.
• W2085285405 cites W2088238276 @default.
• W2085285405 cites W2093940326 @default.
• W2085285405 cites W2101028992 @default.
• W2085285405 cites W2101173190 @default.
• W2085285405 cites W2108658278 @default.
• W2085285405 cites W2109966400 @default.
• W2085285405 cites W2113400447 @default.
• W2085285405 cites W2123825848 @default.
• W2085285405 cites W2127052921 @default.
• W2085285405 cites W2128934286 @default.
• W2085285405 cites W2129223498 @default.
• W2085285405 cites W2148537672 @default.
• W2085285405 cites W2156821940 @default.
• W2085285405 cites W2162160321 @default.
• W2085285405 cites W2163139476 @default.
• W2085285405 cites W2395949811 @default.
• W2085285405 cites W4250179682 @default.
• W2085285405 cites W76674196 @default.
• W2085285405 cites W201820944 @default.
• W2085285405 doi "https://doi.org/10.1016/j.vaccine.2010.02.089" @default.
• W2085285405 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2874835" @default.
• W2085285405 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20206667" @default.
• W2085285405 hasPublicationYear "2010" @default.
• W2085285405 type Work @default.
• W2085285405 sameAs 2085285405 @default.
• W2085285405 citedByCount "58" @default.
• W2085285405 countsByYear W20852854052012 @default.
• W2085285405 countsByYear W20852854052013 @default.
• W2085285405 countsByYear W20852854052014 @default.
• W2085285405 countsByYear W20852854052015 @default.
• W2085285405 countsByYear W20852854052016 @default.
• W2085285405 countsByYear W20852854052017 @default.
• W2085285405 countsByYear W20852854052018 @default.
• W2085285405 countsByYear W20852854052019 @default.
• W2085285405 countsByYear W20852854052020 @default.
• W2085285405 countsByYear W20852854052021 @default.
• W2085285405 countsByYear W20852854052022 @default.
• W2085285405 countsByYear W20852854052023 @default.
• W2085285405 crossrefType "journal-article" @default.
• W2085285405 hasAuthorship W2085285405A5006151816 @default.
• W2085285405 hasAuthorship W2085285405A5007414771 @default.
• W2085285405 hasAuthorship W2085285405A5009314480 @default.
• W2085285405 hasAuthorship W2085285405A5010042657 @default.
• W2085285405 hasAuthorship W2085285405A5015812124 @default.
• W2085285405 hasAuthorship W2085285405A5024322735 @default.
• W2085285405 hasAuthorship W2085285405A5054673363 @default.
• W2085285405 hasAuthorship W2085285405A5069585538 @default.
• W2085285405 hasAuthorship W2085285405A5072701661 @default.
• W2085285405 hasAuthorship W2085285405A5077951736 @default.
• W2085285405 hasBestOaLocation W20852854052 @default.
• W2085285405 hasConcept C126322002 @default.
• W2085285405 hasConcept C141071460 @default.
• W2085285405 hasConcept C168563851 @default.
• W2085285405 hasConcept C203014093 @default.
• W2085285405 hasConcept C22070199 @default.
• W2085285405 hasConcept C2776555147 @default.
• W2085285405 hasConcept C2777625542 @default.
• W2085285405 hasConcept C2778689377 @default.
• W2085285405 hasConcept C2780441014 @default.
• W2085285405 hasConcept C2781257258 @default.
• W2085285405 hasConcept C44249647 @default.

• next